06 Oct 2021 Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer Member news
06 Oct 2021 atbtherapeutics expands leadership team and Scientific Advisory Board with pharmaceutical industry experts Member news
05 Oct 2021 New Flanders360 platform puts Flanders’ life sciences & health ecosystem on the international map Member news
04 Oct 2021 Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease Member news
04 Oct 2021 Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON) Member news
01 Oct 2021 S-Biomedic announces completion of prestigious financing with European Innovation Council Fund Member news
30 Sep 2021 Biotalys strengthens executive team with the appointment of Patrick McDonnell as Chief Business Officer Member news
30 Sep 2021 OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
